NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
13.64
-0.16 (-1.16%)
At close: Jan 16, 2026, 4:00 PM EST
13.64
0.00 (0.00%)
After-hours: Jan 16, 2026, 4:04 PM EST
NovoCure Market Cap
NovoCure has a market cap or net worth of $1.53 billion as of January 16, 2026. Its market cap has decreased by -54.02% in one year.
Market Cap
1.53B
Enterprise Value
1.29B
1-Year Change
-54.02%
Ranking
Category
Stock Price
$13.64
Market Cap Chart
Since October 2, 2015, NovoCure's market cap has increased from $1.51B to $1.53B, an increase of 1.07%. That is a compound annual growth rate of 0.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 14, 2026 | 1.54B | 6.50% |
| Dec 31, 2025 | 1.45B | -55.10% |
| Dec 31, 2024 | 3.22B | 102.11% |
| Dec 29, 2023 | 1.60B | -79.28% |
| Dec 30, 2022 | 7.70B | -1.24% |
| Dec 31, 2021 | 7.79B | -55.75% |
| Dec 31, 2020 | 17.62B | 111.21% |
| Dec 31, 2019 | 8.34B | 167.82% |
| Dec 31, 2018 | 3.11B | 72.52% |
| Dec 29, 2017 | 1.81B | 164.99% |
| Dec 30, 2016 | 681.20M | -63.57% |
| Dec 31, 2015 | 1.87B | 23.71% |
| Oct 2, 2015 | 1.51B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 924.90B |
| Johnson & Johnson | 529.01B |
| AbbVie | 383.08B |
| UnitedHealth Group | 307.04B |
| AstraZeneca | 291.28B |
| Merck & Co. | 275.43B |
| Novartis AG | 273.64B |
| Novo Nordisk | 252.12B |